Tepnel buys Orchid Biosciences

Thanks TTNY (and Soldi) for the extremely detailed summary of the "open day".

Like many I bought into this share on the strength of the business case, and like many I was appalled at the greed eminating from the boardroom. Nontheless distinct signs of progress.

Re:outperformance for 2006 - quite frankly any number would look material against the forecast, so I would caution against over optimism. In any event its the direction and momentum that the business/brokers would be selling so perhaps we can look forward to the drip feeding of positive news announcements which ultimately will reach the ears of non-holders.